CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

November 8, 2023 · earnings

NKTR earnings: a negative outcome, -8.8%

On November 8, 2023, Nektar Therapeutics reached its earnings. The result was a negative outcome, and the stock moved -8.8% in the window around the event. It had already run +7.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$8.22
1d before
$7.50
Event day
$7.12
1d after
$6.73
5d after

Pre-catalyst setup

+7.9%
30-day run-up
6723%
30-day volatility
0.6×
volume spike